Prognostic factors in first-line atezolizumab-bevacizumab treatment of intermediate or advanced hepatocellular carcinoma - Kyowon Gu; Tae Wook Kang; Jaeseung Shin; Dong Hyun Sinn; Myung Ji Goh; Jung Yong Hong; Sangah Chi (PLoS ONE, 2026)